K

Karyopharm Therapeutics Inc.

424 employees

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Basic info

Industry

pharmaceuticals

Sectors

Pharmaceutical
medical
research
healthcare
clinicaltrials
solidtumors
Health Care
drugdiscovery
clinicalresearch
oncology
multiplemyeloma
pharmaceutical
Medical
lymphoma
biotech
glioblastoma

Date founded

2008

Funding rounds raised

Total raised

$165M

from 11 investors over 11 rounds

K

Karyopharm Therapeutics Inc. raised $165M on December 5, 2022

Investors: Adage Capital Management, HEALTHCOR LTD, Armistice Capital LLC, Surveyor Capital, Marshall Wace and Avidity Partners

K

Karyopharm Therapeutics Inc. raised $19M on July 31, 2013

Investors: Delphi Ventures, Foresite Capital and New Leaf Venture Partners

K

Karyopharm Therapeutics Inc. raised $48M on May 20, 2013

Investors: Delphi Ventures

K

Karyopharm Therapeutics Inc. raised $1M on January 6, 2011

Investors: Multiple Myeloma Research Foundation - MMRF

FAQ